CAPSOVISION INC (CV) Stock Price, Forecast & Analysis
NASDAQ:CV • US1409351079
CV Key Statistics, Chart & Performance
The current stock price of CV is 5.49 USD. In the past month the price increased by 1.29%.
CV Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CV.
CV Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CV. CV has a great financial health rating, but its profitability evaluates not so good.
CV Financial Highlights
Over the last trailing twelve months CV reported a non-GAAP Earnings per Share(EPS) of -0.82. The EPS decreased by -76.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -147.38% | ||
| ROE | -185.01% | ||
| Debt/Equity | 0 |
CV Forecast & Estimates
10 analysts have analysed CV and the average price target is 10.71 USD. This implies a price increase of 95.08% is expected in the next year compared to the current price of 5.49.
For the next year, analysts expect an EPS growth of -144.67% and a revenue growth 21.95% for CV
CV Ownership
CV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 20.26 | 202.318B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.26 | 178.812B | ||
| SYK | STRYKER CORP | 25.62 | 148.172B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.94 | 113.97B | ||
| IDXX | IDEXX LABORATORIES INC | 44.32 | 52.44B | ||
| BDX | BECTON DICKINSON AND CO | 11.2 | 50.281B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.08 | 50.178B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.78 | 38.406B | ||
| RMD | RESMED INC | 20.87 | 37.332B | ||
| DXCM | DEXCOM INC | 29.08 | 28.639B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CV
Company Profile
CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Company Info
CAPSOVISION INC
18805 Cox Avenue, Suite 250
Saratoga California CALIFORNIA US
Employees: 0
Phone: 14086241488
CAPSOVISION INC / CV FAQ
What does CV do?
CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Can you provide the latest stock price for CAPSOVISION INC?
The current stock price of CV is 5.49 USD. The price increased by 8.07% in the last trading session.
Does CAPSOVISION INC pay dividends?
CV does not pay a dividend.
What is the ChartMill technical and fundamental rating of CV stock?
CV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What do analysts say about CAPSOVISION INC (CV) stock?
10 analysts have analysed CV and the average price target is 10.71 USD. This implies a price increase of 95.08% is expected in the next year compared to the current price of 5.49.
Can you provide the growth outlook for CAPSOVISION INC?
The Revenue of CAPSOVISION INC (CV) is expected to grow by 21.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for CAPSOVISION INC?
CAPSOVISION INC (CV) has a market capitalization of 257.15M USD. This makes CV a Micro Cap stock.